XTX Topco »

Gain Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2026-06-30 $112k 55k 2.03
2025-09-30 $96k 54k 1.77

More positions owned by XTX Topco

Chevron Corporation (CVX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vaneck Etf Trust Semiconductr Etf (SMH)
Cme (CME)
Netflix (NFLX)
Cisco Systems (CSCO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Pepsi (PEP)
Intercontinental Exchange (ICE)
Boston Scientific Corporation (BSX)
ConocoPhillips (COP)
Meta Platforms Cl A (META)
Analog Devices (ADI)
Electronic Arts (EA)
Quanta Services (PWR)

View all positions for XTX Topco

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
GSA Capital Partners
Jones Financial Companies, L.L
Cambridge Investment Research Advisors
DME Capital Management
Vanguard Capital Management
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
UBS Group
Stratos Wealth Partners
Citadel Advisors
Cresset Asset Management
State Street Corporation

View all funds holding Gain Therapeutics